AI Signal & Stock Analysis · Very Strong ↑
As of Aug 14 2026, 7:49 PM, AkshayaAI's signal for PTGX is Very Strong ↑; the stock is at $155.10 (+2.43% today); overbought (RSI 70); news sentiment is positive.
Data as of Aug 14 2026, 7:49 PM. Informational analytics only — not investment advice.
| AI signal (Strength) | Very Strong ↑ |
|---|---|
| Price | $155.10 |
| Change today | +2.43% |
| RSI (14) | 70.14 |
| Relative volume | 0.63 |
| Composite (RMTPGV) score | 🔒 members |
| Market cap | $10.0B |
| Forward P/E | — |
| 52-week high | 0.1% away |
| 52-week low | +186.3% above |
| Technical trend | — |
| News sentiment | Positive |
| Sector | — |
| Next earnings | 8/5/2026 4:30:00 PM |
As of Aug 14 2026, 7:49 PM, AkshayaAI assigns PTGX (Protagonist Therapeutics Inc) a Very Strong signal. The composite (RMTPGV) score and full factor breakdown are available to signed-in members.
PTGX's RSI is overbought (RSI 70). A reading above 70 is typically considered overbought and below 30 oversold.
PTGX is trading about 0% below its 52-week high and 186% above its 52-week low as of Aug 14 2026, 7:49 PM.
PTGX's next earnings date is 8/5/2026 4:30:00 PM.
AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Aug 14 2026, 7:49 PM and may not reflect real-time prices. Always do your own research. How these signals work →
Instant, data-backed answers — free to try.